Rapid and Efficient Generation of Myelinating Human Oligodendrocytes in Organoids
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shaker, Mohammed R. | - |
dc.contributor.author | Pietrogrande, Giovanni | - |
dc.contributor.author | Martin, Sally | - |
dc.contributor.author | Lee, Ju-Hyun | - |
dc.contributor.author | Sun, Woong | - |
dc.contributor.author | Wolvetang, Ernst J. | - |
dc.date.accessioned | 2021-11-22T22:40:24Z | - |
dc.date.available | 2021-11-22T22:40:24Z | - |
dc.date.created | 2021-08-30 | - |
dc.date.issued | 2021-03-17 | - |
dc.identifier.issn | 1662-5102 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/128404 | - |
dc.description.abstract | Human stem cell derived brain organoids are increasingly gaining attention as an ideal model system for investigating neurological diseases, particularly those that involve myelination defects. However, current protocols for generating brain organoids with sufficiently mature oligodendrocytes that deposit myelin on endogenously produced neurons are lengthy and complicated. Taking advantage of a human pluripotent stem cell line that reports on SOX10 expression, we developed a protocol that involves a 42 day exposure of neuroectoderm-derived organoids to a cocktail of growth factors and small molecules that collectively foster oligodendrocyte specification and survival. Importantly, the resulting day 42 brain organoids contain both myelinating oligodendrocytes, cortical neuronal cells and astrocytes. These oligodendrocyte brain organoids therefore constitute a valuable and tractable platform for functional neurogenomics and drug screening for white matter diseases. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | FRONTIERS MEDIA SA | - |
dc.title | Rapid and Efficient Generation of Myelinating Human Oligodendrocytes in Organoids | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Sun, Woong | - |
dc.identifier.doi | 10.3389/fncel.2021.631548 | - |
dc.identifier.scopusid | 2-s2.0-85103487849 | - |
dc.identifier.wosid | 000635122000001 | - |
dc.identifier.bibliographicCitation | FRONTIERS IN CELLULAR NEUROSCIENCE, v.15 | - |
dc.relation.isPartOf | FRONTIERS IN CELLULAR NEUROSCIENCE | - |
dc.citation.title | FRONTIERS IN CELLULAR NEUROSCIENCE | - |
dc.citation.volume | 15 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.subject.keywordAuthor | oligodendrocyte | - |
dc.subject.keywordAuthor | myelination | - |
dc.subject.keywordAuthor | induced pluripotent stem cells | - |
dc.subject.keywordAuthor | organoid | - |
dc.subject.keywordAuthor | reporter cell line | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.